Studies have shown that LIMK1 is frequently upregulated in various cancers, including gastric cancer, and its overexpression is closely associated with enhanced tumor aggressiveness, lower survival rates, and poor prognosis. This evidence concerns the gene LIMK1 and gastric cancer.